607 related articles for article (PubMed ID: 16399600)
21. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
Bisaccia E; Palangio M; Gonzalez J; Adler KR; Scarborough R; Goldberg SL; Rowley SD
J Clin Apher; 2006 Oct; 21(3):181-7. PubMed ID: 16607632
[TBL] [Abstract][Full Text] [Related]
22. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
[TBL] [Abstract][Full Text] [Related]
23. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
[TBL] [Abstract][Full Text] [Related]
24. Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.
Komanduri KV; Couriel D; Champlin RE
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):1-6. PubMed ID: 16399595
[TBL] [Abstract][Full Text] [Related]
25. The role of the extracorporeal photopheresis in the management of the graft-versus-host disease.
Kaloyannidis P; Mallouri D
Transfus Apher Sci; 2012 Apr; 46(2):211-9. PubMed ID: 22123355
[TBL] [Abstract][Full Text] [Related]
26. Severe intestinal graft versus host disease after donor lymphocyte infusion; response to extracorporeal photochemotherapy.
Vural F; Donmez A; Doganavşargil B; Cagýrgan S; Alper H; Tombuloglu M
Transfus Apher Sci; 2005 Oct; 33(2):129-33. PubMed ID: 16150645
[TBL] [Abstract][Full Text] [Related]
27. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.
Couriel DR; Hosing C; Saliba R; Shpall EJ; Anderlini P; Rhodes B; Smith V; Khouri I; Giralt S; de Lima M; Hsu Y; Ghosh S; Neumann J; Andersson B; Qazilbash M; Hymes S; Kim S; Champlin R; Donato M
Blood; 2006 Apr; 107(8):3074-80. PubMed ID: 16368882
[TBL] [Abstract][Full Text] [Related]
28. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease.
Rossetti F; Dall'Amico R; Crovetti G; Messina C; Montini G; Dini G; Locatelli F; Argiolu F; Miniero R; Zacchello G
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():175-81. PubMed ID: 8932825
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis.
Owsianowski M; Gollnick H; Siegert W; Schwerdtfeger R; Orfanos CE
Bone Marrow Transplant; 1994 Nov; 14(5):845-8. PubMed ID: 7889018
[TBL] [Abstract][Full Text] [Related]
30. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
Lin Q; Dong M; Wang QM; Wen JY; Wu XY
Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
[TBL] [Abstract][Full Text] [Related]
31. Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies.
Abu-Dalle I; Reljic T; Nishihori T; Antar A; Bazarbachi A; Djulbegovic B; Kumar A; Kharfan-Dabaja MA
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1677-86. PubMed ID: 24867779
[TBL] [Abstract][Full Text] [Related]
32. Daclizumab for children with corticosteroid refractory graft-versus-host disease.
Teachey DT; Bickert B; Bunin N
Bone Marrow Transplant; 2006 Jan; 37(1):95-9. PubMed ID: 16247417
[TBL] [Abstract][Full Text] [Related]
33. Care for patients undergoing extracorporeal photopheresis to treat chronic graft-versus-host disease: review of the evidence.
Woltz P; Castro K; Park BJ
Clin J Oncol Nurs; 2006 Dec; 10(6):795-802. PubMed ID: 17193945
[TBL] [Abstract][Full Text] [Related]
34. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
Bladon J; Taylor P
Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
[TBL] [Abstract][Full Text] [Related]
35. Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.
Huff CA; Fuchs EJ; Smith BD; Blackford A; Garrett-Mayer E; Brodsky RA; Flinn IW; Ambinder RF; Borrello IM; Matsui WH; Vogelsang GB; Griffin CA; Luznik L; Jones RJ
Biol Blood Marrow Transplant; 2006 Apr; 12(4):414-21. PubMed ID: 16545725
[TBL] [Abstract][Full Text] [Related]
36. Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation.
Wakui M; Okamoto S; Ishida A; Kobayashi H; Watanabe R; Yajima T; Iwao Y; Hisamatsu T; Hibi T; Ikeda Y
Bone Marrow Transplant; 1999 Mar; 23(6):573-8. PubMed ID: 10217188
[TBL] [Abstract][Full Text] [Related]
37. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.
Ringdén O; Uzunel M; Rasmusson I; Remberger M; Sundberg B; Lönnies H; Marschall HU; Dlugosz A; Szakos A; Hassan Z; Omazic B; Aschan J; Barkholt L; Le Blanc K
Transplantation; 2006 May; 81(10):1390-7. PubMed ID: 16732175
[TBL] [Abstract][Full Text] [Related]
39. Extracorporeal Photopheresis for Non-skin GvHD.
Bittenbring J; Reichrath J
Anticancer Res; 2016 Mar; 36(3):1395-6. PubMed ID: 26977041
[TBL] [Abstract][Full Text] [Related]
40. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
